Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 6/20 | 0.70 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.48 |
| ▸ | DHODH | Q02127 | 4/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL291134 | 1.00 | PDE5A (0.70) | PDE5AMAPTKDM4EALDH1A1LMNA | |
| SCHEMBL291120 | 0.95 | PDE5A (0.76) | PDE5AMAPTKDM4EALDH1A1LMNA | |
| SCHEMBL290739 | 0.93 | PDE5A (0.70) | PDE5AMAPTKDM4EALDH1A1LMNA | |
| SCHEMBL29831813 | 0.93 | PDE5A (0.70) | PDE5AMAPTKDM4EALDH1A1LMNA | |
| SCHEMBL291531 | 0.86 | PDE5A (0.75) | PDE5AMAPTKDM4EALDH1A1LMNA | |
| SCHEMBL29831895 | 0.86 | PDE5A (0.75) | PDE5AMAPTKDM4EALDH1A1LMNA | |
| SCHEMBL291449 | 0.86 | PDE5A (0.64) | PDE5AMAPTKDM4EALDH1A1LMNA | |
| SCHEMBL290735 | 0.86 | PDE5A (0.78) | PDE5AMAPTKDM4EALDH1A1LMNA | |
| SCHEMBL6068322 | 0.86 | PDE5A (0.71) | PDE5AMAPTKDM4EALDH1A1LMNA | |
| SCHEMBL291575 | 0.83 | PDE5A (0.60) | PDE5AMAPTKDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4572765-A1 | USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE | Mitodicure GmbH (DE) | 2025-06-25 | — | — | EP | disclosed |
| WO-2024038089-A1 | USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE | MITODICURE GMBH (DE) | 2024-02-22 | — | — | WO | disclosed |
| CN-115192711-A | Use of PDE7 inhibitors for the treatment of movement disorders | 奥默罗斯公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-114984229-A | Treatment of addiction and impulse control disorders using PDE7 inhibitors | 奥默罗斯公司 | 2022-09-02 | — | — | CN | disclosed |